|
Sulfonylureas Risk Versus Metformin Points to Clear First-Line Diabetes Choice
Using sulfonylureas as a first-line treatment for diabetes is associated with an increased risk for cardiovascular disease events or death compared with the use of metformin, research shows.
medwire News |
Register Now
Archives